Company news
Tilray Brands, Inc. news in 2021
Tilray Brands, Inc.'s news releases, calls and decks from 2021, newest first.
Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022
December 19, 2021
Tilray Strengthens Strategic Position in the U.S. with Acquisition of Breckenridge Distillery
December 7, 2021
Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021
November 15, 2021
Tilray’s Sweetwater Brand Enters Spirits Category Through New Ready-To-Drink Cocktail Now Available in the United States
November 3, 2021
Tilray Expands Medical Cannabis Footprint in Europe
October 25, 2021
Tilray Signs Distribution Agreement With Great North Distributors for Adult-Use Cannabis Sales Across Canada
October 19, 2021
Tilray Strengthens Leadership Position in Canada
October 18, 2021
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
October 6, 2021
Tilray to Announce First Quarter Fiscal 2022 Financial Results on October 7, 2021
September 22, 2021
Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting
September 9, 2021
Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
August 18, 2021
Tilray Acquires Majority Position in Amended MedMen Convertible Notes
August 16, 2021
Tilray Launches New Medical Cannabis Edibles in Canada
August 4, 2021
Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021
July 28, 2021
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
July 27, 2021
Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021
July 14, 2021
Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany
July 6, 2021
Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.
June 29, 2021
Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights
June 28, 2021
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
June 7, 2021
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
May 4, 2021
Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader
May 2, 2021
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
April 15, 2021
Special Meeting of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11: 00 a.m. Eastern Time
April 14, 2021
MAKE YOUR VOTE COUNT!: Tilray Reminds Shareholders to Vote FOR the Proposed Business Combination With Aphria Inc.
April 11, 2021
Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand
March 9, 2021
Aphria and Tilray Announce Launch of www.aphriatilraytogether.com
February 22, 2021
Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results
February 16, 2021
Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021
February 11, 2021
Tilray® Announces Agreement with Grow Pharma to Import and Distribute Medical Cannabis Products in the United Kingdom
February 8, 2021
Tilray® Exports First Shipment of Medical Cannabis to Spain
February 3, 2021
Tilray® Receives the First and Only Market Authorization to Offer Medical Cannabis Products in Portugal
January 31, 2021
Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France
January 25, 2021